Addressing Safety Concerns in the Treatment of Atopic Dermatitis
Faculty: Jon Hanifin, MD | Mark Boguniewicz, MD | Adelaide Hebert, MD | Jonathan Spergel, MD, PhD
CME / CE credit hour: 1.0
In this CME activity, four distinguished members of the medical community review and discuss current clinical trial data focusing on safety issues surrounding the use of topical corticosteroid and TCIs. Panel members review the potential short- and long-term adverse effects of each drug class and then place this information into context by evaluating the risk-benefit ratio associated with each treatment.

Current Perspectives in Epilepsy Treatment: Focus on Monotherapy
(Accreditation Expired)
Faculty: John M. Pellock, MD | Michael D. Privitera, MD
CME credit hour: 1.0
Combination therapy with antiepileptic drugs is associated with a variety of complications, including toxicity and the potential for drug interactions. In addition, many patients who do not respond to sequential monotherapy, will not become seizure-free with polytherapy. Monotherapy has several advantages over polytherapy, including a reduced risk of side effects and complications due to drug interactions, lower cost, and better compliance. hts issues relating to the use of newer antiepileptic drugs as monotherapy in the treatment of adults and children with epilepsy.

Pediatric Epilepsy: Identifying & Treating Different Seizure Types
Faculty: John M. Pellock, MD | James W. Wheless, MD | Patricia Dean, ARNP, MSN
CME Credit hour: 1.0
Nearly one-third of the population newly diagnosed with epilepsy each year is children. More specifically, 45,000 children under the age of 15 develop epilepsy each year. Classification of seizure disorders has evolved considerably over time and many new treatment options have become available in recent years. For the majority of patients, seizures can be adequately controlled without unendurable side effects. This program will examine issues and considerations related to identifying seizure types and managing epilepsy in pediatric patients.

All information content within shall be considered confidential property of ArcMesa Educators, LLC
and should not be disclosed or redistributed to third parties without express permission.